Boxer Capital, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 36 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$1,522,000
+39.2%
138,3310.0%0.35%
+33.1%
Q2 2017$1,093,000
-31.0%
138,3310.0%0.26%
-24.9%
Q1 2017$1,584,000
-1.7%
138,3310.0%0.35%
-44.6%
Q4 2016$1,612,000
-13.0%
138,3310.0%0.62%
-24.8%
Q3 2016$1,852,000
+0.1%
138,331
+48.2%
0.83%
-49.4%
Q2 2016$1,850,000
+18.2%
93,3310.0%1.64%
+7.1%
Q1 2016$1,565,00093,3311.53%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders